These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7738710)

  • 21. [Pathogenetic pharmacotherapy of erectile dysfunction].
    Dorofeev SD; Paniushkin SM; Efremov EA
    Urologiia; 2007; (3):107-11. PubMed ID: 17722630
    [No Abstract]   [Full Text] [Related]  

  • 22. [Role of vascular nitric oxide in experimental liver cirrhosis].
    Atucha NM; Nadal FJ; Iyu D; García-Estañ J
    Nefrologia; 2002; 22 Suppl 5():25-8. PubMed ID: 12107913
    [No Abstract]   [Full Text] [Related]  

  • 23. L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
    Böger RH
    Curr Opin Clin Nutr Metab Care; 2008 Jan; 11(1):55-61. PubMed ID: 18090660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide mechanisms of nebivolol.
    Maffei A; Lembo G
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):317-27. PubMed ID: 19443516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelium-derived nitric oxide in the control of tissue perfusion and oxygen supply: physiological and pathophysiological implications.
    Pohl U; Wagner K; de Wit C
    Eur Heart J; 1993 Nov; 14 Suppl I():93-8. PubMed ID: 8293786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The scientific impact of the nitric oxide discovery as vasodilator and endogenous antithrombotic agent].
    Evora PR
    Arq Bras Cardiol; 1993 Jul; 61(1):3-5. PubMed ID: 8285862
    [No Abstract]   [Full Text] [Related]  

  • 27. Ulster says 'NO'; explosion, resistance and tolerance. Nitric oxide and the actions of organic nitrates.
    Johnston GD
    Ulster Med J; 1998 Nov; 67(2):79-90. PubMed ID: 9885543
    [No Abstract]   [Full Text] [Related]  

  • 28. [The L-arginine-nitric oxide system: physiology, physiopathology and clinical relevance].
    Garini G; Savazzi G; Borghetti A
    Recenti Prog Med; 1997 Feb; 88(2):90-9. PubMed ID: 9148375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide and cardiovascular system.
    Cengel A; Sahinarslan A
    Anadolu Kardiyol Derg; 2006 Dec; 6(4):364-8. PubMed ID: 17162286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NO in the cardiovascular system.
    Shah AM; Vallance P; Harrison D
    Cardiovasc Res; 1999 Aug; 43(3):507-8. PubMed ID: 10690322
    [No Abstract]   [Full Text] [Related]  

  • 31. Nitric oxide in heart failure: friend or foe.
    Jugdutt BI
    Heart Fail Rev; 2002 Oct; 7(4):385-9. PubMed ID: 12379823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of endothelial dysfunction in humans.
    Hornig B; Drexler H
    Coron Artery Dis; 2001 Sep; 12(6):463-73. PubMed ID: 11696685
    [No Abstract]   [Full Text] [Related]  

  • 33. Nitric oxide and myocardial function in heart failure: friend or foe?
    Cotton JM; Kearney MT; Shah AM
    Heart; 2002 Dec; 88(6):564-6. PubMed ID: 12433878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide biology: implications for cardiovascular therapeutics.
    Warren JB; Pons F; Brady AJ
    Cardiovasc Res; 1994 Jan; 28(1):25-30. PubMed ID: 8111788
    [No Abstract]   [Full Text] [Related]  

  • 35. Nitric Oxide Donors and the Treatment of Cardiovascular Disease. Proceedings of a symposium. New Orleans, Louisiana, November 15, 1992.
    J Cardiovasc Pharmacol; 1993; 22 Suppl 7():S1-58. PubMed ID: 7504761
    [No Abstract]   [Full Text] [Related]  

  • 36. The potential clinical impact of 20 years of nitric oxide research.
    Cohen RA
    Am J Physiol; 1999 Apr; 276(4):H1404-7. PubMed ID: 10199869
    [No Abstract]   [Full Text] [Related]  

  • 37. Hyperlipidaemia and cardiovascular disease.
    Khan N
    Curr Opin Lipidol; 2000 Apr; 11(2):215-7. PubMed ID: 10787185
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects of Thrombospondin-1 on cardiovascular disease: Friend or foe?
    Mo D; Liu J; Li H
    Int J Cardiol; 2023 Apr; 377():19. PubMed ID: 36738842
    [No Abstract]   [Full Text] [Related]  

  • 39. The Effects of Dexamethasone on Cardiovascular Disease: Friend or Foe?
    Han QF; Liu JH; Mo DG
    Cardiovasc Drugs Ther; 2023 Oct; 37(5):847-848. PubMed ID: 36001199
    [No Abstract]   [Full Text] [Related]  

  • 40. The hemosteoblast: friend or foe?
    Tintut Y; Demer L
    Circ Res; 2011 Apr; 108(9):1038-9. PubMed ID: 21527740
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.